Bryan D Cox1, Richard A Stanton1, Raymond F Schinazi2. 1. Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, USA. 2. Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, USA rschina@emory.edu.
Abstract
BACKGROUND: Zika virus is an emerging crisis as infection is implicated in severe neurological disorders-Guillain-Barré syndrome and fetal microcephaly. There are currently no treatment options available for Zika virus infection. This virus is part of the flavivirus genus and closely related to Dengue Fever Virus, West Nile Virus, and Japanese Encephalitis Virus. Like other flaviviruses, the Zika virus genome encodes three structural proteins (capsid, precursor membrane, and envelope) and seven nonstructural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5). Currently, no structural information exists on these viral proteins to facilitate vaccine design and rational drug discovery. METHODS: Structures for all Zika virus viral proteins were predicted using experimental templates available from closely related viruses using the online SwissModel server. These homology models were compared to drug targets from other viruses using Visual Molecular Dynamics Multiseq software. Sequential alignment of all Zika virus polyproteins was performed using Clustal Omega to identify mutations in specific viral proteins implicated in pathogenesis. RESULTS: The precursor membrane, envelope, and NS1 proteins are unique to Zika virus highlighting possible challenges in vaccine design. Sequential differences between Zika virus strains occur at critical positions on precursor membrane, envelope, NS2A, NS3, NS4B, and NS5 as potential loci for differential pathogenesis. Druggable pockets in Dengue Fever Virus and West Nile Virus NS3 and NS5 are retained in predicted Zika virus structures. CONCLUSIONS: Lead candidates for Zika virus can likely be established using NS3 and NS5 inhibitors from other flaviviruses, and the structures presented can provide opportunities for Zika virus intervention strategies.
BACKGROUND:Zika virus is an emerging crisis as infection is implicated in severe neurological disorders-Guillain-Barré syndrome and fetal microcephaly. There are currently no treatment options available for Zika virus infection. This virus is part of the flavivirus genus and closely related to Dengue Fever Virus, West Nile Virus, and Japanese Encephalitis Virus. Like other flaviviruses, the Zika virus genome encodes three structural proteins (capsid, precursor membrane, and envelope) and seven nonstructural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5). Currently, no structural information exists on these viral proteins to facilitate vaccine design and rational drug discovery. METHODS: Structures for all Zika virus viral proteins were predicted using experimental templates available from closely related viruses using the online SwissModel server. These homology models were compared to drug targets from other viruses using Visual Molecular Dynamics Multiseq software. Sequential alignment of all Zika virus polyproteins was performed using Clustal Omega to identify mutations in specific viral proteins implicated in pathogenesis. RESULTS: The precursor membrane, envelope, and NS1 proteins are unique to Zika virus highlighting possible challenges in vaccine design. Sequential differences between Zika virus strains occur at critical positions on precursor membrane, envelope, NS2A, NS3, NS4B, and NS5 as potential loci for differential pathogenesis. Druggable pockets in Dengue Fever Virus and West Nile Virus NS3 and NS5 are retained in predicted Zika virus structures. CONCLUSIONS: Lead candidates for Zika virus can likely be established using NS3 and NS5 inhibitors from other flaviviruses, and the structures presented can provide opportunities for Zika virus intervention strategies.
Authors: Siew Pheng Lim; Louis Sebastian Sonntag; Christian Noble; Shahul H Nilar; Ru Hui Ng; Gang Zou; Paul Monaghan; Ka Yan Chung; Hongping Dong; Boping Liu; Christophe Bodenreider; Gladys Lee; Mei Ding; Wai Ling Chan; Gang Wang; Yap Li Jian; Alexander Theodore Chao; Julien Lescar; Zheng Yin; T R Vedananda; Thomas H Keller; Pei-Yong Shi Journal: J Biol Chem Date: 2010-12-08 Impact factor: 5.157
Authors: Devika Sirohi; Zhenguo Chen; Lei Sun; Thomas Klose; Theodore C Pierson; Michael G Rossmann; Richard J Kuhn Journal: Science Date: 2016-03-31 Impact factor: 47.728
Authors: Bruno Guy; Farshad Guirakhoo; Veronique Barban; Stephen Higgs; Thomas P Monath; Jean Lang Journal: Vaccine Date: 2009-10-04 Impact factor: 3.641
Authors: Todd C Appleby; Jason K Perry; Eisuke Murakami; Ona Barauskas; Joy Feng; Aesop Cho; David Fox; Diana R Wetmore; Mary E McGrath; Adrian S Ray; Michael J Sofia; S Swaminathan; Thomas E Edwards Journal: Science Date: 2015-02-13 Impact factor: 47.728
Authors: Gang Zou; Francesc Puig-Basagoiti; Bo Zhang; Min Qing; Liqiang Chen; Krzysztof W Pankiewicz; Krzysztof Felczak; Zhiming Yuan; Pei-Yong Shi Journal: Virology Date: 2008-12-05 Impact factor: 3.616
Authors: Ge Li; Melissa Poulsen; Csaba Fenyvuesvolgyi; Yoko Yashiroda; Minoru Yoshida; J Marc Simard; Robert C Gallo; Richard Y Zhao Journal: Proc Natl Acad Sci U S A Date: 2017-01-03 Impact factor: 11.205
Authors: Matthew T Aliota; Leda Bassit; Shelton S Bradrick; Bryan Cox; Mariano A Garcia-Blanco; Christina Gavegnano; Thomas C Friedrich; Thaddeus G Golos; Diane E Griffin; Andrew D Haddow; Esper G Kallas; Uriel Kitron; Marc Lecuit; Diogo M Magnani; Caroline Marrs; Natalia Mercer; Edward McSweegan; Lisa F P Ng; David H O'Connor; Jorge E Osorio; Guilherme S Ribeiro; Michael Ricciardi; Shannan L Rossi; George Saade; Raymond F Schinazi; Geraldine O Schott-Lerner; Chao Shan; Pei-Yong Shi; David I Watkins; Nikos Vasilakis; Scott C Weaver Journal: Antiviral Res Date: 2017-06-06 Impact factor: 5.970
Authors: Rahul Mittal; Desiree Nguyen; Luca H Debs; Amit P Patel; George Liu; Vasanti M Jhaveri; Sae-In S Kay; Jeenu Mittal; Emmalee S Bandstra; Ramzi T Younis; Prem Chapagain; Dushyantha T Jayaweera; Xue Zhong Liu Journal: Front Cell Infect Microbiol Date: 2017-12-08 Impact factor: 5.293
Authors: Christina Gavegnano; Leda C Bassit; Bryan D Cox; Hui-Mien Hsiao; Erica L Johnson; Mehul Suthar; Rana Chakraborty; Raymond F Schinazi Journal: Pathog Immun Date: 2017-05-24